Research output

Research output per year 2012 2021 2022 2022

• 13 Journal article
• 5 Review article
• 3 Conference contribution to journal
• 1 Chapter in book/report
• 1 More
  • 1 Editorial

Research output per year

Research output per year

Search results

• 2022

  Editorial: Innate lymphocytes in tumor surveillance

  Fritz, J. H. & Stoiber, D., 23 Nov 2022, In: Frontiers in Immunology. 13, p. 1093318 1093318.

  Research output: Journal article (peer-reviewed) › Editorial

  Open Access

• P399: UNRAVELING THE TUMOR SUPPRESSIVE ROLE OF STAT3Β IN ACUTE MYELOID LEUKEMIA

  Edtmayer, S., Witalisz-Siepracka, A., Zdársky, B., Eder, T., Poli, V., Grebien, F. & Stoiber, D., 2022, In: HemaSphere. 6, p. 299-300

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• P483: STAT3 DRIVES IMMUNE EVASION OF MLL-AF9-DRIVEN ACUTE MYELOID LEUKEMIA

  Zdarsky, B., Witalisz-Siepracka, A., Boigenzahn, S., Fiedler, K. & Stoiber, D., 2022, In: HemaSphere. 6, p. 382-383

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  Open Access

• PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma

  Garces de Los Fayos Alonso, I., Zujo, L., Wiest, I., Kodajova, P., Timelthaler, G., Edtmayer, S., Zrimšek, M., Kollmann, S., Giordano, C., Kothmayer, M., Neubauer, H. A., Dey, S., Schlederer, M., Schmalzbauer, B. S., Limberger, T., Probst, C., Pusch, O., Högler, S., Tangermann, S., Merkel, O., & 20 othersSchiefer, A. I., Kornauth, C., Prutsch, N., Zimmerman, M., Abraham, B., Anagnostopoulos, J., Quintanilla-Martinez, L., Mathas, S., Wolf, P., Stoiber, D., Staber, P. B., Egger, G., Klapper, W., Woessmann, W., Look, T. A., Gunning, P., Turner, S. D., Moriggl, R., Lagger, S. & Kenner, L., Dec 2022, In: Molecular Cancer. 21, 1, p. 172 1 p., 172.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • Lymphoma 100%
  • STAT3 83%
  • Anaplastic Large Cell Lymphoma 83%
  • STAT5 50%
  • Growth 33%

• The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance

  Witalisz-Siepracka, A., Klein, K., Zdársky, B. & Stoiber, D., 5 Jul 2022, In: Frontiers in Immunology. 13, p. 947568 947568.

  Research output: Journal article (peer-reviewed) › Review article

  Open Access

  • STAT3 100%
  • Natural Killer Cell 69%
  • Tumor Cell 30%
  • Immunotherapy 7%
  • Adaptive Immune System 7%
  3 Citations (Scopus)

• The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma

  Lind, J., Hellinger, R., Kudweis, P., Moll, H. E., Gattringer, J., Thell, K., Edtmayer, S., Gruber, C. W., Stoiber, D. & Kollmann, K., Sept 2022, In: Biomedicine and Pharmacotherapy. 153, 113486.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • Peptide 100%
  • Anaplastic Large Cell Lymphoma 100%
  • Cyclotide 100%
  • Neoplasm 66%
  • Programmed Cell Death 66%
• 2021

  Beneficial Metabolic Effects of TREM2 in Obesity Are Uncoupled From Its Expression on Macrophages

  Sharif, O., Brunner, J. S., Korosec, A., Martins, R., Jais, A., Snijder, B., Vogel, A., Caldera, M., Hladik, A., Lakovits, K., Saluzzo, S., Boehm, B., Gorki, A-D., Mesteri, I., Lindroos-Christensen, J., Tillmann, K., Stoiber, D., Menche, J., Schabbauer, G., Bilban, M., & 3 othersSuperti-Furga, G., Esterbauer, H. & Knapp, S., 1 Sept 2021, In: Diabetes. 70, 9, p. 2042-2057 16 p.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • Triggering Receptor Expressed on Myeloid Cells 2 100%
  • Myeloid 100%
  • Obesity 55%
  • Health 44%
  • Adipose Tissue 44%
  18 Citations (Scopus)

• Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs Inducing Synergistic Anti-Myeloma Activity

  Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Fan, F., Zwickl-Traxler, E., Stoiber, D., Bakiri, L., Wagner, E. F., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, In: Blood. 138, Supplement 1, 2644.

  Research output: Journal article (peer-reviewed) › Journal article

  • Multiple Myeloma 100%
  • Interleukin-6 60%
  • Bone Marrow Stromal Cell 40%
  • Trametinib 40%
  • Oncogene C Myc 40%

• Down-regulation of A20 promotes immune escape of lung adenocarcinomas

  Breitenecker, K., Homolya, M., Luca, A. C., Lang, V., Trenk, C., Petroczi, G., Mohrherr, J., Horvath, J., Moritsch, S., Haas, L., Kurnaeva, M., Eferl, R., Stoiber, D., Moriggl, R., Bilban, M., Obenauf, A. C., Ferran, C., Dome, B., Laszlo, V., Győrffy, B., & 4 othersDezso, K., Moldvay, J., Casanova, E. & Moll, H. P., 7 Jul 2021, In: Science Translational Medicine. 13, 601, eabc3911.

  Research output: Journal article (peer-reviewed) › Journal article

  • Lung 100%
  • Immune Checkpoint Blockade 57%
  • Carcinogenesis 42%
  • STAT1 Protein 42%
  • Cytotoxic T-Cell 42%
  3 Citations (Scopus)

• Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness

  Grandits, A. M., Nguyen, C. H., Schlerka, A., Hackl, H., Sill, H., Etzler, J., Heyes, E., Stoiber, D., Grebien, F., Heller, G. & Wieser, R., Oct 2021, In: Leukemia. 35, 10, p. 2827-2839 13 p.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • Chemotherapy 100%
  • Acute Myeloid Leukemia 100%
  • Myeloid 100%
  • Diseases 50%
  • down Regulation 50%
  4 Citations (Scopus)

• OAB-030: Combined targeting of distinct c-Myc and JunB transcriptional programs induces synergistic anti-myeloma activity: 18th International Myeloma Workshop, 08.-11.09.2021, Vienna, Austria

  Lind, J., Vallet, S., Kollmann, K., Aksoy, O., Sunder-Plassmann, V., Zwickl-Traxler, E., Fan, F., Stoiber-Sakaguchi, D., Bakiri, L., Wagner, E., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, p. S19-S20

  Research output: Journal article (peer-reviewed) › Conference contribution to journal

  • Multiple Myeloma 100%
  • Bone Marrow Stromal Cell 50%
  • Trametinib 50%
  • Interleukin-6 50%
  • Transcription Factor 37%

• Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma

  Liang, H-C., Costanza, M., Prutsch, N., Zimmerman, M. W., Gurnhofer, E., Montes-Mojarro, I. A., Abraham, B. J., Prokoph, N., Stoiber, S., Tangermann, S., Lobello, C., Oppelt, J., Anagnostopoulos, I., Hielscher, T., Pervez, S., Klapper, W., Zammarchi, F., Silva, D-A., Garcia, K. C., Baker, D., & 23 othersJanz, M., Schleussner, N., Fend, F., Pospíšilová, Š., Janiková, A., Wallwitz, J., Stoiber, D., Simonitsch-Klupp, I., Cerroni, L., Pileri, S., de Leval, L., Sibon, D., Fataccioli, V., Gaulard, P., Assaf, C., Knörr, F., Damm-Welk, C., Woessmann, W., Turner, S. D., Look, A. T., Mathas, S., Kenner, L. & Merkel, O., 1 Dec 2021, In: Nature Communications. 12, 1, p. 5577 5577.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • Anaplastic Large Cell Lymphoma 100%
  • Anaplastic Lymphoma Kinase 16%
  • Receptor 16%
  • Enhancer Region 16%
  • Lymphoma Cell 16%
  7 Citations (Scopus)

• The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia

  Moser, B., Edtmayer, S., Witalisz-Siepracka, A. & Stoiber, D., 19 Aug 2021, In: Biomedicines. 9, 8, 1051.

  Research output: Journal article (peer-reviewed) › Review article

  Open Access

  • Myeloid 100%
  • Acute Myeloid Leukemia 100%
  • Janus Kinase 100%
  • Clinical Trial 50%
  • Transcription 50%
  4 Citations (Scopus)

• Tumor suppressors in acute myeloid leukemia

  Wallwitz, J., Aigner, P. & Stoiber, D., Oct 2021, In: Leukemia and Lymphoma. 62, 10, p. 2320-2330 11 p.

  Research output: Journal article (peer-reviewed) › Review article

  Open Access

  • Tumor Suppressor Protein 100%
  • Acute Myeloid Leukemia 33%
  • Myeloid 33%
  • Diseases 11%
  • Neoplasm 11%
  4 Citations (Scopus)

• Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?

  Klein, K., Stoiber, D., Sexl, V. & Witalisz-Siepracka, A., 1 Jun 2021, In: Cancers. 13, 11, 2611.

  Research output: Journal article (peer-reviewed) › Review article

  Open Access

  • Janus Kinase Inhibitor 100%
  • Therapeutic Procedure 80%
  • Cancer 60%
  • Patient 60%
  • Myeloproliferative Neoplasm 60%
  10 Citations (Scopus)
• 2020

  Platelet-Leukocyte Interplay in Cancer Development and Progression

  Stoiber, D. & Assinger, A., 1 Apr 2020, In: Cells. 9, 4

  Research output: Journal article (peer-reviewed) › Review article

  Open Access

  • Platelet 100%
  • Neoplasm 75%
  • Leukocyte 62%
  • Malignant Neoplasm 62%
  • Metastatic Carcinoma 37%
  39 Citations (Scopus)
• 2019

  CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia

  Gluexam, T., Grandits, A. M., Schlerka, A., Nguyen, C. H., Etzler, J., Finkes, T., Fuchs, M., Scheid, C., Heller, G., Hackl, H., Harrer, N., Sill, H., Koller, E., Stoiber, D., Sommergruber, W. & Wieser, R., 1 Dec 2019, In: International Journal of Molecular Sciences. 20, 23, 5826.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • Myeloid 100%
  • Acute Myeloid Leukemia 81%
  • CALCRL 54%
  • Calcitonin Gene Related Peptide 54%
  • Stem Cell 36%
  16 Citations (Scopus)

• STAT3β is a tumor suppressor in acute myeloid leukemia

  Aigner, P., Mizutani, T., Horvath, J., Eder, T., Heber, S., Lind, K., Just, V., Moll, H. P., Yeroslaviz, A., Fischer, M. J. M., Kenner, L., Győrffy, B., Sill, H., Grebien, F., Moriggl, R., Casanova, E. & Stoiber, D., 9 Jul 2019, In: Blood advances. 3, 13, p. 1989-2002 14 p.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • STAT3 100%
  • Myeloid 46%
  • RNA Sequence 6%
  • Mouse Model 6%
  • Overall Survival 6%
  11 Citations (Scopus)

• Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritis

  Wallwitz, J., Aigner, P., Gadermaier, E., Bauer, E., Casanova, E., Bauer, A. & Stoiber, D., 1 Aug 2019, In: PLoS ONE. 14, 8, p. e0220935 e0220935.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • Endostatin 100%
  • Mouse 36%
  • Biological Marker 27%
  • Glomerulonephritis 27%
  • Enzyme-Linked Immunosorbent Assay 27%
  4 Citations (Scopus)
• 2017

  Natural killer cell-intrinsic type I IFN signaling controls Klebsiella pneumoniae growth during lung infection

  Ivin, M., Dumigan, A., de Vasconcelos, F. N., Ebner, F., Borroni, M., Kavirayani, A., Przybyszewska, K. N., Ingram, R. J., Lienenklaus, S., Kalinke, U., Stoiber, D., Bengoechea, J. A. & Kovarik, P., Nov 2017, In: PLoS Pathogens. 13, 11, p. e1006696 e1006696.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • Interferon Type I 100%
  • Natural Killer Cell 70%
  • Alveolar Macrophage 40%
  • Host 30%
  • Lung 20%
  33 Citations (Scopus)
• 2015

  Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis

  Grabner, B., Schramek, D., Mueller, K. M., Moll, H. P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., Stiedl, P., Nivarthi, H., Bogner, E., Gruber, W., Mohr, T., Zwick, R. H., Kenner, L., Poli, V., Aberger, F., Stoiber, D., & 9 othersEgger, G., Esterbauer, H., Zuber, J., Moriggl, R., Eferl, R., Győrffy, B., Penninger, J. M., Popper, H. & Casanova, E., 4 Mar 2015, In: Nature Communications. 6, p. 6285 6285.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • STAT3 100%
  • KRAS 55%
  • Mutant 33%
  • Survival 22%
  • Mutation 11%
  106 Citations (Scopus)

• Methods to study tumor surveillance using tumor cell transplantation into genetically engineered mice

  Bauer, E., Witalisz, A., Strobl, B. & Stoiber, D., 30 Jan 2015, Mouse Models of Cancer: Methods and Protocols. Springer New York, Vol. 1267. p. 439-456 18 p. (Methods in molecular biology (Clifton, N.J.)).

  Research output: Contribution to book/report/conference proceeding › Chapter in book/report

  • Neoplasm 100%
  • Surveillance 75%
  • Tumor Cell 75%
  • Genetically Engineered Mouse Strain 75%
  • Cancer Transplantation 50%
• 2012

  Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance

  Mizutani, T., Neugebauer, N., Putz, E. M., Moritz, N., Simma, O., Zebedin-Brandl, E., Gotthardt, D., Warsch, W., Eckelhart, E., Kantner, H-P., Kalinke, U., Lienenklaus, S., Weiss, S., Strobl, B., Müller, M., Sexl, V. & Stoiber, D., 1 Oct 2012, In: OncoImmunology. 1, 7, p. 1027-1037 11 p.

  Research output: Journal article (peer-reviewed) › Journal article

  Open Access

  • Natural Killer Cell 100%
  • Mouse 66%
  • IFNAR1 55%
  • Interferon Type I 44%
  • Animal 22%
  42 Citations (Scopus)